209 related articles for article (PubMed ID: 27761963)
1. Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway.
Egashira I; Takahashi-Yanaga F; Nishida R; Arioka M; Igawa K; Tomooka K; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Kitazono T; Sasaguri T
Cancer Sci; 2017 Jan; 108(1):108-115. PubMed ID: 27761963
[TBL] [Abstract][Full Text] [Related]
2. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs diclofenac and celecoxib attenuates Wnt/β-catenin/Tcf signaling pathway in human glioblastoma cells.
Sareddy GR; Kesanakurti D; Kirti PB; Babu PP
Neurochem Res; 2013 Nov; 38(11):2313-22. PubMed ID: 24013885
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib-induced degradation of T-cell factors-1 and -4 in human colon cancer cells.
Takahashi-Yanaga F; Yoshihara T; Jingushi K; Miwa Y; Morimoto S; Hirata M; Sasaguri T
Biochem Biophys Res Commun; 2008 Dec; 377(4):1185-90. PubMed ID: 18983819
[TBL] [Abstract][Full Text] [Related]
6. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
[TBL] [Abstract][Full Text] [Related]
7. DIF-1 inhibits tumor growth in vivo reducing phosphorylation of GSK-3β and expressions of cyclin D1 and TCF7L2 in cancer model mice.
Takahashi-Yanaga F; Yoshihara T; Jingushi K; Igawa K; Tomooka K; Watanabe Y; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Sasaguri T
Biochem Pharmacol; 2014 Jun; 89(3):340-8. PubMed ID: 24670930
[TBL] [Abstract][Full Text] [Related]
8. Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway.
Srivastava S; Dewangan J; Mishra S; Divakar A; Chaturvedi S; Wahajuddin M; Kumar S; Rath SK
Phytomedicine; 2021 Apr; 84():153484. PubMed ID: 33667839
[TBL] [Abstract][Full Text] [Related]
9. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
10. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo.
Kubokura N; Takahashi-Yanaga F; Arioka M; Yoshihara T; Igawa K; Tomooka K; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Matsumoto T; Kitazono T; Sasaguri T
J Pharmacol Sci; 2015 Apr; 127(4):446-55. PubMed ID: 25913757
[TBL] [Abstract][Full Text] [Related]
11. Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
Maier TJ; Janssen A; Schmidt R; Geisslinger G; Grösch S
FASEB J; 2005 Aug; 19(10):1353-5. PubMed ID: 15946992
[TBL] [Abstract][Full Text] [Related]
12. R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells.
Behari J; Zeng G; Otruba W; Thompson MD; Muller P; Micsenyi A; Sekhon SS; Leoni L; Monga SP
J Hepatol; 2007 May; 46(5):849-57. PubMed ID: 17275129
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
[TBL] [Abstract][Full Text] [Related]
14. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
15. 2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation.
Morishige S; Takahashi-Yanaga F; Ishikane S; Arioka M; Igawa K; Kuroo A; Tomooka K; Shiose A; Sasaguri T
Biochem Pharmacol; 2019 Oct; 168():82-90. PubMed ID: 31229551
[TBL] [Abstract][Full Text] [Related]
16. [Periplocin extracted from cortex periplocae induces apoptosis of SW480 cells through inhibiting the Wnt/beta-catenin signaling pathway].
Du YY; Liu X; Shan BE
Ai Zheng; 2009 May; 28(5):456-60. PubMed ID: 19624870
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.
Dakeng S; Duangmano S; Jiratchariyakul W; U-Pratya Y; Bögler O; Patmasiriwat P
J Cell Biochem; 2012 Jan; 113(1):49-60. PubMed ID: 21866566
[TBL] [Abstract][Full Text] [Related]
18. γ-Tocotrienol inhibits cell viability through suppression of β-catenin/Tcf signaling in human colon carcinoma HT-29 cells.
Xu W; Du M; Zhao Y; Wang Q; Sun W; Chen B
J Nutr Biochem; 2012 Jul; 23(7):800-7. PubMed ID: 21852086
[TBL] [Abstract][Full Text] [Related]
19. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
20. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
